<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04099355</url>
  </required_header>
  <id_info>
    <org_study_id>7815</org_study_id>
    <nct_id>NCT04099355</nct_id>
  </id_info>
  <brief_title>Investigating the Effect of Dronabinol on Post-surgical Pain</brief_title>
  <official_title>Investigating the Effect of Dronabinol on Post-surgical Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York State Psychiatric Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York State Psychiatric Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to investigate the effect of dronabinol on post operative pain in&#xD;
      patients undergoing total knee replacement (for their own clinical care).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total knee replacement is a common surgical procedure that restores function to the damaged&#xD;
      joint. Recovery from this procedure takes weeks and requires opioids to manage post-surgical&#xD;
      pain. The goal of this study is to investigate whether dronabinol (synthetic THC) can reduce&#xD;
      pain and the need for opioid medication following this particular surgery.&#xD;
&#xD;
      Subjects will be recruited from the Department of Orthopedic Surgery. All subjects will&#xD;
      undergo total knee replacement as part of their clinical care (the surgery itself is not part&#xD;
      of this study). The study begins following discharge from the hospital. They will be asked to&#xD;
      take dronabinol or placebo as they recover from surgery. During this time they will be given&#xD;
      their usual pain medications at discharge which includes opioids for pain. The opioids are to&#xD;
      be taken if the subject is experiencing pain. The investigator's hypothesis is that subjects&#xD;
      taking dronabinol will need fewer doses of opioids to control pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">August 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brief Pain Inventory-Short Form</measure>
    <time_frame>2 weeks</time_frame>
    <description>pain assessment, self report measure of pain, scale 0-10 (10 worst)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>opioid medication log</measure>
    <time_frame>two weeks</time_frame>
    <description>opioid use by participant for pain after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Knee Replacement</condition>
  <condition>Arthropathy of Knee</condition>
  <arm_group>
    <arm_group_label>dronabinol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>active group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dronabinol 5mg Cap</intervention_name>
    <description>PO QHS 14 days</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>dronabinol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Non-active comparator</intervention_name>
    <description>PO QHS 14 days</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>dronabinol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants undergoing total knee arthroplasty (TKA) at the CUIMC department of&#xD;
             orthopedic surgery as part of their clinical care.&#xD;
&#xD;
          -  Able to give informed consent and comply with study procedures in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Meet DSM-V criteria for current major psychiatric illness, such as bipolar disorder,&#xD;
             major depression, or psychosis. Subjects with a current substance use disorder will be&#xD;
             excluded. Subjects with a past cannabis use disorder are excluded.&#xD;
&#xD;
          -  Diagnosis of a major medical or neurological disorder, including orthostatic&#xD;
             hypertension, cardiovascular disease (congestive heart failure, unstable angina, or a&#xD;
             history of cardiac infarction), hypotension, or neurodegenerative disorders.&#xD;
&#xD;
          -  Subjects taking medications that can lead to a drug interaction.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diana Martinez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYSPI</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diana Martinez</last_name>
    <phone>646-774-7654</phone>
    <email>dm437@columbia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>1051 Riverside Drive</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Martinez, MD</last_name>
      <phone>646-774-7654</phone>
      <email>dm437@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Diana Martinez, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 19, 2019</study_first_submitted>
  <study_first_submitted_qc>September 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2019</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York State Psychiatric Institute</investigator_affiliation>
    <investigator_full_name>Diana Martinez</investigator_full_name>
    <investigator_title>Psychiatrist II</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dronabinol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

